PDUFA Negotiations: FDA Wants To Be Able To Call "Time-Out" During Reviews

FDA has proposed a new application review model that would allow it to call a time-out, which could be used to resolve mid-cycle issues and, the agency argues, potentially bring more predictability to the process.